- Home
- INTS vs ADN Comparison
INTS vs ADN Comparison
Compare INTS & ADN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- ADN
- Stock Information
- Founded
- INTS 2012
- ADN 2006
- Country
- INTS United States
- ADN United States
- Employees
- INTS N/A
- ADN N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- ADN Power Generation
- Sector
- INTS Health Care
- ADN Utilities
- Exchange
- INTS Nasdaq
- ADN Nasdaq
- Market Cap
- INTS 12.2M
- ADN 10.0M
- IPO Year
- INTS 2023
- ADN N/A
- Fundamental
- Price
- INTS $0.31
- ADN $2.87
- Analyst Decision
- INTS Strong Buy
- ADN
- Analyst Count
- INTS 4
- ADN 0
- Target Price
- INTS $4.50
- ADN N/A
- AVG Volume (30 Days)
- INTS 5.0M
- ADN 192.3K
- Earning Date
- INTS 11-12-2025
- ADN 08-12-2025
- Dividend Yield
- INTS N/A
- ADN N/A
- EPS Growth
- INTS N/A
- ADN N/A
- EPS
- INTS N/A
- ADN N/A
- Revenue
- INTS N/A
- ADN $115,000.00
- Revenue This Year
- INTS N/A
- ADN $6,528.51
- Revenue Next Year
- INTS N/A
- ADN N/A
- P/E Ratio
- INTS N/A
- ADN N/A
- Revenue Growth
- INTS N/A
- ADN N/A
- 52 Week Low
- INTS $0.19
- ADN $1.71
- 52 Week High
- INTS $3.75
- ADN $8.79
- Technical
- Relative Strength Index (RSI)
- INTS 64.31
- ADN 38.35
- Support Level
- INTS $0.27
- ADN $3.25
- Resistance Level
- INTS $0.30
- ADN $3.35
- Average True Range (ATR)
- INTS 0.03
- ADN 0.30
- MACD
- INTS 0.01
- ADN -0.04
- Stochastic Oscillator
- INTS 60.25
- ADN 2.13
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About ADN Advent Technologies Holdings Inc.
Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space, including liquid hydrogen carriers such as methanol. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.